SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-48993"
 

Search: onr:"swepub:oai:DiVA.org:oru-48993" > International renal...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • McCredie, M.Cancer Epidemiology Research Unit, NSW Cancer Council, Sydney, Australia (author)

International renal-cell cancer study. II. Analgesics

  • Article/chapterEnglish1995

Publisher, publication year, extent ...

  • New York, USA :John Wiley & Sons,1995
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-48993
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-48993URI
  • https://doi.org/10.1002/ijc.2910600312DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • There has been concern about the role of analgesics in the development of renal-cell cancer, although a few studies have reported moderately elevated risks with regular or long-term use. In a large international case-control study of renal-cell cancer we examined, among other hypotheses, the effect of phenacetin-containing and of other types of analgesics: paracetamol (acetaminophen), salicylates (mainly aspirin) and pyrazolones (e.g., antipyrine or phenazone). Relative risks, adjusted for the effects of age, sex, body-mass index, tobacco smoking and study centre, were not significantly increased with intake of phenacetin, either when lifetime consumption was categorized at the level of > or = 0.1 kg or when subjects were subdivided further by amount. Nor were paracetamol, salicylates or pyrazolones linked with renal-cell cancer. No consistently increasing risks with consumption level was found. The lack of association was not altered by restricting analgesic use to that which occurred 5 or 10 years before the defined "cut-off" date or when analysis was restricted to exclusive users of a particular type of analgesic. Neither was the risk influenced by the rate of consumption or whether the consumption had occurred at a young age. Our study provides clear evidence that aspirin is unrelated to renal-cell cancer risk, and our findings do not support the hypothesis that analgesics containing phenacetin or paracetamol increase the risk, although the number of "regular" users and the amount of these types of analgesic consumed were too small to confidently rule out a minor carcinogenic effect of phenacetin and paracetamol.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Pommer, W.Humboldt Hospital, Berlin, Germany (author)
  • McLaughlin, J. K.Biostatistics Branch, National Cancer Institute, Bethesda, Maryland, United States (author)
  • Stewart, J. H.Western Clinical School, University of Sydney, Sydney, Australia (author)
  • Lindblad, Per,1953-Department of Cancer Epidemiology, University Hospital, Uppsala, Sweden(Swepub:oru)pld (author)
  • Mandel, J. S.School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States (author)
  • Mellemgaard, A.Copenhagen, Denmark (author)
  • Schlehofer, B.Division of Epidemiology, German Cancer Research Centre, Heidelberg, Germany (author)
  • Niwa, S.Westat Inc., Rockville, Maryland, United States (author)
  • Cancer Epidemiology Research Unit, NSW Cancer Council, Sydney, AustraliaHumboldt Hospital, Berlin, Germany (creator_code:org_t)

Related titles

  • In:International Journal of CancerNew York, USA : John Wiley & Sons60:3, s. 345-3490020-71361097-0215

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view